ASSOCIATION OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 WITH HYPERTENSION AND SMOKING
Инновационная медицина Кубани, 2019 Objectives. To estimate the relationship of proprotein convertase subtilisin/kexin type 9 (PCSK9) level with blood pressure (BP) and smoking in a population of young males in Novosibirsk.Material and methods.
K. S. Benimetskaya +6 more
doaj +2 more sources
FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
Global Cardiology Science and Practice, 2017 [first paragraph of article]The 2003 discovery of proprotein convertase subtilisin–kexin type-9 (PCSK9) – a circulating protein targeting the low density lipoprotein (LDL) receptor for its degradation – paved the way for the development of several therapeutic approaches which inhibit the protein itself (by monoclonal antibodies) or its RNA (by RNA ...
openaire +3 more sources
PCSK9 and Breast Cancer Survival: A Mendelian Randomization Study. [PDF]
Cancer Epidemiol Biomarkers PrevPott J +5 more
europepmc +1 more source
A narrative review of PCSK9 inhibitors: from evolocumab to novel discoveries. [PDF]
Front PharmacolLiu HH, Li S, Li JJ.
europepmc +1 more source
Phenolic Compounds with PCSK9 Secretion Inhibitory Activities from the Fruits of <i>Liriope spicata</i>. [PDF]
ACS OmegaZheng R +7 more
europepmc +1 more source
Knowledge, Attitudes, and Practices Regarding PCSK9 Inhibitors Among Healthcare Professionals: Exploring Behavioral Pathways and the Intermediary Role of Attitude. [PDF]
J Multidiscip HealthcZhao C, Wang N, Shen D, Zhu L, Chen G.
europepmc +1 more source
PCSK9 Inhibitor Use and the Risk of Age-Related Macular Degeneration in Patients with Atherosclerotic Cardiovascular Disease. [PDF]
Pharmaceuticals (Basel)Tsai HR, Hsu JZ, Loh CH, Huang HK.
europepmc +1 more source
Association Between PCSK9 Inhibitor Use and Risk of Age-Related Macular Degeneration. [PDF]
Transl Vis Sci TechnolTsai CY +7 more
europepmc +1 more source